Related Experiment Video
Updated: May 21, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Cardio-ankle vascular index in heterozygous familial hypercholesterolemia
Vladimir Soska1, Petr Dobsak, Ladislav Dusek
12nd Clinic of Internal Medicine, Masaryk University of Brno, Czech Republic. vladimir.soska@fnusa.cz
Aim:
The cardio-ankle vascular index (CAVI) is a new non-invasive marker of arterial stiffness and atherosclerosis. The purpose of this study was to compare CAVI in patients with heterozygous familial hypercholesterolemia (FH) and in healthy controls.
Methods:
82 FH subjects (27 males, 65 females), aged 53.7±13.6 years without clinical symptoms of cardiovascular diseases and 359 healthy controls (121 males, 238 females), aged 43.9±14.9 years, were examined. CAVI was measured using the system VaSera® 1500.
Results:
CAVI in FH patients was significantly higher (8.0±1.4) than in healthy subjects (7.5±1.3) p = 0.002; however, age, sex and BMI adjusted CAVI did not differ significantly (p = 0.061) between the FH group (7.5, CI: 7.3; 7.7) and control group (7.7, CI: 7.6; 7.7).
Conclusion:
The study showed no significant difference in CAVI between heterozygous FH and healthy controls.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
